Curcumin inhibits NF-κB activation and reduces the severity of experimental steatohepatitis in mice
- 2 September 2004
- journal article
- research article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 41 (6), 926-934
- https://doi.org/10.1016/j.jhep.2004.08.010
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- The IκB-NF-κB Signaling Module: Temporal Control and Selective Gene ActivationScience, 2002
- IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokinesAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2002
- Etiopathogenesis of Nonalcoholic SteatohepatitisSeminars in Liver Disease, 2001
- NF-κB: a key role in inflammatory diseasesJCI Insight, 2001
- CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitisJCI Insight, 2000
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological LesionsAmerican Journal of Gastroenterology, 1999
- Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆Gastroenterology, 1999
- Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importanceJournal of Hepatology, 1998
- Steatohepatitis: A tale of two “hits”?Gastroenterology, 1998